[Acute meningitidis, acute phase proteins and procalcitonin]

Area of Science:

• Infectious Diseases
• Clinical Microbiology
• Biomarkers

Background:

• Bacterial meningitis diagnosis is time-sensitive, with initial treatment often presumptive due to unreliable early clinical and biological parameters.
• C-reactive protein (CRP) is commonly used but its independent diagnostic value for bacterial meningitis is debated.
• Procalcitonin (PCT) is an acute-phase protein with rapid kinetics, making it a potential early diagnostic marker.

Purpose of the Study:

• To evaluate the diagnostic accuracy of Procalcitonin (PCT) in differentiating bacterial meningitis from viral meningitis.
• To compare the effectiveness of PCT with C-reactive protein (CRP) in early meningitis diagnosis.
• To assess the utility of PCT in guiding antibiotic treatment duration.

Main Methods:

• Review of studies evaluating PCT and CRP in meningitis diagnosis.
• Analysis of sensitivity and specificity of PCT using a cut-off range of 0.5-2 ng/mL.
• Examination of PCT's role in clinical management, including antibiotic treatment duration.

Main Results:

• Early studies indicated 100% sensitivity and specificity for PCT in distinguishing bacterial from viral meningitis within a specific concentration range.
• Subsequent studies supported the usefulness of PCT in meningitis diagnosis.
• PCT effectively reduced unnecessary antibiotic treatment in pediatric patients.

Conclusions:

• Procalcitonin (PCT) is a highly sensitive and specific biomarker for bacterial meningitis.
• PCT offers advantages over CRP for early and accurate diagnosis of bacterial meningitis.
• PCT can be a valuable tool for optimizing antibiotic therapy in meningitis cases.